Vivanza Biosciences has informed that pursuant to Regulation 29 and other applicable provisions of the Listing Regulations, a Meeting of the Board of Directors of the Company will be held on Friday November 11, 2022, to consider and approve the unaudited Financial Results of the Company for the quarter and half year ended on September 30, 2022 and to take on record the Limited Review Report thereon and any other business with the permission of Chair. In accordance with the 'Vivanza' Code of Conduct for Prevention of Insider Trading' pursuant to the amended SEBI (Prohibition of Insider Trading) Regulations, 2015, the Company has intimated its Designated Persons regarding the closure of the trading window which had commenced on Saturday, October 01, 2022 and will end 48 hours after the results are made public.
The above information is a part of company’s filings submitted to BSE.